Montalban X, Wallace D, Genovese MC, Tomic D, et al. Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis. J Neurol Neurosurg Psychiatry 2022 Nov 23:jnnp-2022-328799.
PMID: 36418156